Home
Conditions
Hepatitis, Chronic

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

NCT01320943

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +26 more
Locations: Leberzentrum am Checkpoint Berlin, Germany

Charite CVK Berlin, Germany

Zentrum für HIV und Hepatitis Düsseldorf, Germany

J.W. Goethe Universitaetsklinikum Frankfurt, Germany

View all 13 locations

View Trial Details

Completed

Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection

NCT02027116

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Pusan National University Hospital Pusan, South Korea

Yonsei University Severance Hospital Seoul, South Korea

View Trial Details

Completed

Lamivudine and Adefovir Dipivoxil Fixed Dose Combination

NCT01353742

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Shatin, New Territories, Hong Kong

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil

NCT02442271

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)

NCT02624063

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Outpatient Clinic of Viral Hepatitis (NUPAIG) São Paulo, Brazil

View Trial Details

Completed

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

NCT01730508

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: The Fifth Hospital of Shijiazhuang Baoding, China

Beijing Ditan Hospital Beijing, China

Beijing 302 Hospital; No. 2 Infectious Disease Section Beijing, China

Beijing Friendship Hospital Beijing, China

View all 88 locations

View Trial Details

Completed

SR-BI and Antiviral Treatment Response in HCV

NCT02714712

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis

NCT02219477

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Not specified

View Trial Details

Completed

Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B Patients

NCT02387463

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Beijing Ditan hospital,Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Completed

Long-Term Lamivudine Therapy for Chronic Hepatitis B

NCT00120354

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Chronic Disease, +18 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Hepatitis, Chronic

Hepatitis, Chronic trial results

Related conditions